Combined Application of Pulsed RF and Steroids to the DRG for PHN
Study Details
Study Description
Brief Summary
Recently, the use of pulsed radiofrequency has increased in many chronic pain conditions, including trigeminal neuralgia, chronic spinal pain, musculoskeletal pain, and it was recently used effectively for postherpetic neuralgia. Transforaminal epidural steroid injection has been proven in previous studies to provide effective analgesia for cases of herpes zoster-related pain. We hypothesize that the combined use of pulsed RF and steroid injection applied to the DRG may achieve better outcomes than the use of pulsed RF alone.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Varicella-zoster virus reactivates in sensory ganglia as the dorsal root ganglion (DRG). The DRG contains many receptor channels and is an important region for pain signal transduction. Sustained abnormal electrical activity to the spinal cord via the DRG in acute herpes zoster can result in neuropathic conditions such as postherpetic neuralgia (PHN). Postherpetic neuralgia (PHN) is the final stage of varicella-zoster infection and is manifested as severe refractory neuropathic pain. Preventing the transition of herpes zoster-related pain to PHN is a very important therapeutic principle for patients at an early stage, especially for older patients. The exact discriminative time point for PHN has not yet been standardized. Various criteria have been used, from 30 days to 180 days after zoster onset. If pain persists for more than 180 days after zoster onset, the likelihood of pain reduction is very low and such a condition is considered "well established" PHN. Therefore, it is advisable to actively attempt various treatment modalities for pain control before the condition progresses to a recalcitrant state. Pulsed radiofrequency (PRF) is a variant of thermal radiofrequency that applies pulsed current to limit heat generation to less than 42˚C, creating a little risk of thermal or nerve injury. Recently, the use of PRF has increased in many chronic pain conditions, including trigeminal neuralgia, chronic spinal pain, musculoskeletal pain, and it was recently used effectively for postherpetic neuralgia. Transforaminal epidural steroid injection has been proven in previous studies to provide effective analgesia for cases of herpes zoster-related pain. We hypothesize that combined use of pulsed RF and steroid injection applied to the DRG may achieve a better outcome than use of pulsed RF alone.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: PRF group Pulsed radiofrequency application to the dorsal root ganglion of the affected dermatome of herpes zoster related pain in affected patients |
Procedure: PRF
Pulsed radiofrequency with temperature 42 degrees for 6 minutes to be applied to the dorsal root ganglion of affected dermatomes
|
| Active Comparator: PRF plus steroids group Pulsed radiofrequency plus Depo-Medrol (steroid) application to the dorsal root ganglion of the affected dermatome of herpes zoster related pain in affected patients |
Procedure: PRF plus steroids injection
Pulsed radiofrequency with temperature 42 degrees for 6 minutes to be applied to the dorsal root ganglion plus injection of Depo-Medrol of affected dermatomes
|
Outcome Measures
Primary Outcome Measures
- Numerical rating scale [Up to 6 months after the intervention]
Numerical rating scale (the 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable") to be recorded before intervention and at one week, 1 month , 2 months, and 3 months and 6 months after intervention.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients with ASA I&II status
-
Thoracic zoster related pain
-
less than three months duration from the appearance of shingles
Exclusion Criteria:
-
coagulopathy
-
local infection
-
patient refusal
-
Diabetes Melliteus
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Zagazig university hospital | Zagazig | Ash-sharqia | Egypt | 44511 |
Sponsors and Collaborators
- Mansoura University
- Zagazig University
Investigators
- Principal Investigator: Mahmoud M Alseoudy, MD, mansoura university, faculty of medicine
- Study Director: khadega Elhossieny, MD, Zagazig University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ZU-IRB#9199